Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
B 35.28 2.95% 1.01
PTGX closed down 0.93 percent on Wednesday, January 19, 2022, on 1.12 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical PTGX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 2.95%
Fell Below 20 DMA Bearish 2.95%
MACD Bearish Signal Line Cross Bearish 2.95%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.95%
Outside Day Range Expansion 2.95%
Fell Below 200 DMA Bearish 1.99%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.99%
NR7 Range Contraction 1.99%
Inside Day Range Contraction 1.99%
20 DMA Support Bullish -1.89%
Older End-of-Day Signals for PTGX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 25 minutes ago
Up 3% about 1 hour ago
Up 2% about 2 hours ago
Rose Above 20 DMA about 2 hours ago
20 DMA Support about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Proprietary Technology Inflammatory Bowel Disease Ulcer Ulcerative Colitis Colitis Abdominal Pain Crohn's Disease EPC Chemical Entities Epci Gi Disease Hepcidin

Is PTGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.54
52 Week Low 12.8
Average Volume 556,739
200-Day Moving Average 35.86
50-Day Moving Average 33.93
20-Day Moving Average 34.49
10-Day Moving Average 34.83
Average True Range 1.99
ADX 18.12
+DI 15.90
-DI 20.97
Chandelier Exit (Long, 3 ATRs) 31.09
Chandelier Exit (Short, 3 ATRs) 34.29
Upper Bollinger Bands 36.26
Lower Bollinger Band 32.73
Percent B (%b) 0.44
BandWidth 10.25
MACD Line 0.52
MACD Signal Line 0.56
MACD Histogram -0.0358
Fundamentals Value
Market Cap 1.31 Billion
Num Shares 38.3 Million
EPS -2.74
Price-to-Earnings (P/E) Ratio -12.50
Price-to-Sales 26.02
Price-to-Book 4.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.33
Resistance 3 (R3) 37.62 36.88 36.82
Resistance 2 (R2) 36.88 36.10 36.74 36.65
Resistance 1 (R1) 35.58 35.62 35.21 35.29 36.48
Pivot Point 34.84 34.84 34.66 34.70 34.84
Support 1 (S1) 33.54 34.06 33.17 33.25 32.06
Support 2 (S2) 32.80 33.58 32.66 31.89
Support 3 (S3) 31.50 32.80 31.72
Support 4 (S4) 31.21